I agree that this site is using cookies. You can find further informations here.
X
Alosaimy, Sara
80  results:
Search for persons X
?
1

Eravacycline, the first four years: health outcomes and tol..:

Kunz Coyne, Ashlan J. ; Alosaimy, Sara ; Lucas, Kristen...
Microbiology Spectrum.  12 (2024)  1 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
2

Understanding vancomycin nephrotoxicity augmented by β-lact..:

Alosaimy, Sara ; Rybak, Michael J ; Sakoulas, George
The Lancet Infectious Diseases.  24 (2024)  3 - p. e179-e188 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Dalbavancin Sequential Therapy for Gram-Positive Bloodstrea..:

Rebold, Nicholas ; Alosaimy, Sara ; Pearson, Jeffrey C....
Infectious Diseases and Therapy.  13 (2024)  3 - p. 565-579 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Risk Factors for Carbapenem-ResistantEnterobacteralesClinic..:

Rebold, Nicholas ; Lagnf, Abdalhamid M. ; Alosaimy, Sara...
Microbiology Spectrum.  11 (2023)  1 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
5

Long-term evaluation of clinical success and safety of omad..:

El Ghali, Amer ; Morrisette, Taylor ; Alosaimy, Sara...
Antimicrobial Agents and Chemotherapy.  67 (2023)  10 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
6

Clinical Characteristics Associated with Bacterial Bloodstr..:

Rebold, Nicholas ; Alosaimy, Sara ; Morrisette, Taylor...
Infectious Diseases and Therapy.  11 (2022)  3 - p. 1281-1296 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Culturally sensitive recommendations for the clinical pharm..:

Alosaimy, Sara ; Mohammad, Insaf ; Chahine, Elias B....
JACCP:JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.  5 (2022)  8 - p. 875-886 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Reply to Scheetz et al:

Alosaimy, Sara ; Rybak, Michael J ; Sakoulas, George
Clinical Infectious Diseases.  76 (2022)  8 - p. 1522-1523 , 2022
Link: https://doi.org/10.1093/..
 
?
9

Real-World, Multicenter Case Series of Patients Treated wit..:

Morrisette, Taylor ; Alosaimy, Sara ; Lagnf, Abdalhamid M....
Infectious Diseases and Therapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
10

679. Traditional vs. Alternative Agents in Patients with Lo..:

Holger, Dana J ; Lagnf, Abdalhamid M ; Belza, Ana Christine...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
11

Nephrotoxicity of Vancomycin in Combination With Beta-Lacta..:

Alosaimy, Sara ; Lagnf, Abdalhamid M ; Hobbs, Athena L V...
Clinical Infectious Diseases.  76 (2022)  3 - p. e1444-e1455 , 2022
Link: https://doi.org/10.1093/..
 
?
12

Clinical Outcomes of Eravacycline in Patients Treated Predo..:

Alosaimy, Sara ; Morrisette, Taylor ; Lagnf, Abdalhamid M....
Microbiology Spectrum.  10 (2022)  5 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
13

Impact of Ceftolozane–Tazobactam vs. Best Alternative Thera..:

Holger, Dana J. ; Rebold, Nicholas S. ; Alosaimy, Sara...
Infectious Diseases and Therapy.  11 (2022)  5 - p. 1965-1980 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Early Multicenter Experience With Imipenem-Cilastatin-Releb..:

Rebold, Nicholas ; Morrisette, Taylor ; Lagnf, Abdalhamid M...
Open Forum Infectious Diseases.  8 (2021)  12 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
15

COVID-19: Before the Fall, An Evidence-Based Narrative Revi..:

Rebold, Nicholas ; Holger, Dana ; Alosaimy, Sara..
Infectious Diseases and Therapy.  10 (2021)  1 - p. 93-113 , 2021
Link: https://doi.org/10.1007/..
 
1-15